218 related articles for article (PubMed ID: 30693001)
61. Suppression of CD4+ Effector Responses by Naturally Occurring CD4+ CD25+ Foxp3+ Regulatory T Cells Contributes to Experimental Cerebral Malaria.
Blanc AL; Keswani T; Gorgette O; Bandeira A; Malissen B; Cazenave PA; Pied S
Infect Immun; 2016 Jan; 84(1):329-38. PubMed ID: 26553468
[TBL] [Abstract][Full Text] [Related]
62. Iron prevents the development of experimental cerebral malaria by attenuating CXCR3-mediated T cell chemotaxis.
Van Den Ham KM; Shio MT; Rainone A; Fournier S; Krawczyk CM; Olivier M
PLoS One; 2015; 10(3):e0118451. PubMed ID: 25768944
[TBL] [Abstract][Full Text] [Related]
63. Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria.
Brant F; Miranda AS; Esper L; Gualdrón-López M; Cisalpino D; de Souza DDG; Rachid MA; Tanowitz HB; Teixeira MM; Teixeira AL; Machado FS
Brain Behav Immun; 2016 May; 54():73-85. PubMed ID: 26765997
[TBL] [Abstract][Full Text] [Related]
64. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria.
Belnoue E; Potter SM; Rosa DS; Mauduit M; Grüner AC; Kayibanda M; Mitchell AJ; Hunt NH; Rénia L
Parasite Immunol; 2008 Oct; 30(10):544-53. PubMed ID: 18665903
[TBL] [Abstract][Full Text] [Related]
65. Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.
Blank J; Behrends J; Jacobs T; Schneider BE
Infect Immun; 2016 Feb; 84(2):502-10. PubMed ID: 26644378
[TBL] [Abstract][Full Text] [Related]
66. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
67. The Liver-Stage
Sato Y; Ries S; Stenzel W; Fillatreau S; Matuschewski K
Front Immunol; 2019; 10():2554. PubMed ID: 31736970
[TBL] [Abstract][Full Text] [Related]
68. Activated Brain Endothelial Cells Cross-Present Malaria Antigen.
Howland SW; Poh CM; Rénia L
PLoS Pathog; 2015 Jun; 11(6):e1004963. PubMed ID: 26046849
[TBL] [Abstract][Full Text] [Related]
69. CD80 Expressed by CD8
Rollins MR; Gibbons Johnson RM
J Immunol Res; 2017; 2017():7659462. PubMed ID: 29181416
[TBL] [Abstract][Full Text] [Related]
70. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
White KL; Snyder HL; Krzych U
J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
[TBL] [Abstract][Full Text] [Related]
71. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria.
McQuillan JA; Mitchell AJ; Ho YF; Combes V; Ball HJ; Golenser J; Grau GE; Hunt NH
Int J Parasitol; 2011 Feb; 41(2):155-63. PubMed ID: 20828575
[TBL] [Abstract][Full Text] [Related]
72. Common strategies to prevent and modulate experimental cerebral malaria in mouse strains with different susceptibilities.
Randall LM; Amante FH; McSweeney KA; Zhou Y; Stanley AC; Haque A; Jones MK; Hill GR; Boyle GM; Engwerda CR
Infect Immun; 2008 Jul; 76(7):3312-20. PubMed ID: 18474652
[TBL] [Abstract][Full Text] [Related]
73. Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.
Huggins MA; Johnson HL; Jin F; N Songo A; Hanson LM; LaFrance SJ; Butler NS; Harty JT; Johnson AJ
Infect Immun; 2017 May; 85(5):. PubMed ID: 28264905
[TBL] [Abstract][Full Text] [Related]
74. The PD-1: PD-L1 pathway promotes development of brain-resident memory T cells following acute viral encephalitis.
Prasad S; Hu S; Sheng WS; Chauhan P; Singh A; Lokensgard JR
J Neuroinflammation; 2017 Apr; 14(1):82. PubMed ID: 28407741
[TBL] [Abstract][Full Text] [Related]
75. β-Adrenergic Signaling Impairs Antitumor CD8
Nissen MD; Sloan EK; Mattarollo SR
Cancer Immunol Res; 2018 Jan; 6(1):98-109. PubMed ID: 29146881
[TBL] [Abstract][Full Text] [Related]
76. Site-specific regulation of oral mucosa-recruiting CD8
Hirunwidchayarat W; Furusawa E; Kang S; Ohno T; Takeuchi S; Rungsiyanont S; Azuma M
Biochem Biophys Res Commun; 2017 Sep; 490(4):1294-1300. PubMed ID: 28687491
[TBL] [Abstract][Full Text] [Related]
77. PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis.
Nie M; Liu Y; Li XX; Min YN; Yang DD; Li Q; Feng Q; Hou Y; Li GS; Sun JZ; Hou M; Shi Y
Thromb Haemost; 2019 May; 119(5):758-765. PubMed ID: 30808044
[TBL] [Abstract][Full Text] [Related]
78. Fenozyme Protects the Integrity of the Blood-Brain Barrier against Experimental Cerebral Malaria.
Zhao S; Duan H; Yang Y; Yan X; Fan K
Nano Lett; 2019 Dec; 19(12):8887-8895. PubMed ID: 31671939
[TBL] [Abstract][Full Text] [Related]
79. IL-10 participates in the expansion and functional activation of CD8
Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
[TBL] [Abstract][Full Text] [Related]
80. Protein kinase C-theta is required for development of experimental cerebral malaria.
Fauconnier M; Bourigault ML; Meme S; Szeremeta F; Palomo J; Danneels A; Charron S; Fick L; Jacobs M; Beloeil JC; Ryffel B; Quesniaux VF
Am J Pathol; 2011 Jan; 178(1):212-21. PubMed ID: 21224058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
